FRMD5 and cancer: Since depletion of FRMD5 displays mixed oncogenic activity depending on the cancer cell mutational status, the expressional profile of P-gp-, BCRP-, MRP1- and MRP6-encoding genes was evaluated in FRMD5-knocked-down TPC1 and BCPAP cells using RT-qPCR.